The overall goal is to define the catabolic pathways of surfactant in vivo. Surfactant clearance rates differ in developing and adult animals, and rates of clearance and metabolic fate are important factors that need to be considered in the use of exogenously administered surfactants for the treatment of respiratory distress syndrome in preterm infants and for the potential treatment of patients with the adult respiratory distress syndrome. Experiments are designed to evaluate possible effects of exogenous surfactants on endogenous surfactant metabolic pathways. These experiments utilize a combination of intravascular and intratracheal labels to trace the metabolism of surfactant phosphatidylcholine. Techniques will be developed to isolate lysosomes and multivesicular bodies from lung homogenates and primary isolates of type II cells. The subcellular fractionation scheme is designed to recover organelles that are components of surfactant recycling and catabolic pathways. These pathways will be probed by tracking radiolabeled surfactant phosphatidylcholine and phosphatidylcholine analogues (lyso phosphatidylcholine and the ether linked analogue) through lung and type II cell subcellular fractions. The radiolabeled analogues are chosen to permit more specific identification of the pathways and their function. The same subcellular fractionation technique will be applied to lung homogenates and type II cells from animals treated with radiolabeled surfactant following pretreatment with agents known to interfere with lysosomal catabolic activity (amiodarone and/or chlorphenteramine). These experiments are designed to evaluate the contribution of lysosomes to catabolism. Other experiments will combine radiolabeled hydrophobic surfactant proteins with surfactant to measure the clearance of the surfactant proteins and their effects on surfactant metabolism. These experiments then will be extended to a lung injury model induced by N-nitroso-N-methylurethane to evaluate the effects of lung injury on the catabolism and clearance of treatment doses of surfactant. The experiments in aggregate will quantify surfactant catabolic pathways, and the effects of development and lung injury on those pathways. By selective use of tract or treatment doses of surfactant, the results will characterize both normal pathways and pathways that may be important following surfactant treatment.
| Ikegami, Machiko; Dhami, Rajwinder; Schuchman, Edward H (2003) Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol 284:L518-25 |
| Glasser, Stephan W; Detmer, Emily A; Ikegami, Machiko et al. (2003) Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 278:14291-8 |
| Gurel, O; Ikegami, M; Chroneos, Z C et al. (2001) Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am J Physiol Lung Cell Mol Physiol 280:L1266-72 |
| Kramer, B W; Jobe, A H; Ikegami, M (2001) Exogenous surfactant changes the phenotype of alveolar macrophages in mice. Am J Physiol Lung Cell Mol Physiol 280:L689-94 |
| Rider, E D; Ikegami, M; Pinkerton, K E et al. (2000) Lysosomes from rabbit type II cells catabolize surfactant lipids. Am J Physiol Lung Cell Mol Physiol 278:L68-74 |
| Ikegami, M; Whitsett, J A; Chroneos, Z C et al. (2000) IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol 278:L75-80 |
| Elhalwagi, B M; Zhang, M; Ikegami, M et al. (1999) Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol 21:380-7 |
| Jobe, A H; Ikegami, M (1998) Surfactant homeostasis in corticotropin-releasing hormone deficiency in adult mice. Am J Respir Crit Care Med 158:995-7 |
| Ikegami, M; Korfhagen, T R; Whitsett, J A et al. (1998) Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 275:L247-54 |
| Ikegami, M; Horowitz, A D; Whitsett, J A et al. (1998) Clearance of SP-C and recombinant SP-C in vivo and in vitro. Am J Physiol 274:L933-9 |
Showing the most recent 10 out of 62 publications
